MinervaX Provides Clinical Update on its Maternal GBS Vaccine

14/02/2022

MinervaX Provides Clinical Update on its Maternal GBS Vaccine MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces significant clinical progress on its maternal GBS vaccine.  ...

Sunstone Life Science Ventures is looking for a Student Assistant

04/01/2022

Sunstone Life Science Ventures is looking for a Student Assistant No longer accepting applications We are looking for a student to join our team for approximately 8 hours a week. As part of the team, you will play a pivotal role in the management of our deal flow,...

Who is in the driver’s seat of our industry?

23/11/2021

A recent analysis from Pharma Intelligence | Informa 2021 highlights the current trends of pipeline products (top panel). We have subsequently surveyed Sunstone’s incoming deal flow for the same period and noted the correlation for the top 3 categories with oncology...

Synendos Therapeutics Appoints Scientific Advisory Board

26/10/2021

Synendos Therapeutics Appoints Scientific Advisory Board Synendos Therapeutics (Synendos), a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to treat Central Nervous System (CNS) disorders, today announces the...

MinervaX provides clinical and leadership update

07/10/2021

MinervaX provides clinical and leadership update MinervaX, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces clinical progress on its maternal GBS vaccine as well as multiple additions to its...